| RS1312511221 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1312522259 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1312528958 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Infantile hypophosphatasia |
| RS1312537519 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1312555296 |
TRAPPC2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1312589379 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1312607495 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 42, early-onset |
| RS1312613088 |
TTN
|
Health Risk |
Likely pathogenic |
Tibial muscular dystrophy, Tibial muscular dystrophy |
| RS1312622774 |
EOGT
|
Health Risk |
Pathogenic/Likely pathogenic |
Adams-Oliver syndrome 4, Adams-Oliver syndrome 4 |
| RS1312633998 |
GRM7
|
Health Risk |
Pathogenic |
— |
| RS1312664315 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1312672769 |
CYP21A2
|
Health Risk |
Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1312678560 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS1312683854 |
GP1BA
|
Health Risk |
Pathogenic |
— |
| RS1312702973 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1312712049 |
CCDC40
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS1312714061 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1312716558 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1312725371 |
DOCK8
|
Health Risk |
Pathogenic |
-, - |
| RS1312735736 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1312739762 |
DDHD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS1312743513 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1312750144 |
ITGA6
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa, junctional 6 |
| RS1312758061 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1312765862 |
CPAMD8
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 8, Anterior segment dysgenesis 8 |
| RS1312772215 |
EIF2B5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukoencephalopathy with vanishing white matter 5, Leukoencephalopathy with vanishing white matter 5 |
| RS1312776461 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS1312837709 |
TRIM37
|
Health Risk |
Likely pathogenic |
— |
| RS1312854010 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1312862210 |
RHO
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 4, Retinitis pigmentosa 4 |
| RS1312865574 |
KIAA0753
|
Health Risk |
Pathogenic |
Joubert syndrome 38, Joubert syndrome 38 |
| RS1312908190 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1312908957 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1312967591 |
OCA2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism, Oculocutaneous albinism |
| RS1312971608 |
UBE3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Angelman syndrome |
| RS1312980498 |
FOXH1
|
Health Risk |
Likely pathogenic |
Conotruncal defect, Conotruncal defect |
| RS1313006784 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1313008538 |
ABCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Arterial calcification |
| RS1313027554 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS1313042151 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1313055571 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1313057342 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS1313066818 |
CYP21A2
|
Health Risk |
Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1313068805 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1313071575 |
UBA5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS1313081073 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1313088429 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS1313089322 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy, Nemaline myopathy |
| RS1313098392 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1313101326 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1313103908 |
LTBP3
|
Health Risk |
Likely pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS1313114326 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1313115089 |
AGBL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1313120333 |
MMUT
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1313143328 |
FANCM
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1313151909 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1313165721 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1313166263 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1313171285 |
SPOP
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies, Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies |
| RS1313203471 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1313206550 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1313207845 |
RFXAP
|
Health Risk |
Pathogenic/Likely pathogenic |
MHC class II deficiency, MHC class II deficiency 4 |
| RS1313233245 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1313255190 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS1313261352 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1313275799 |
AP4E1
|
Health Risk |
Pathogenic |
ALG12-congenital disorder of glycosylation, Hereditary spastic paraplegia 51 |
| RS1313277352 |
SLC16A2
|
Health Risk |
Likely pathogenic |
SLC16A2-related disorder, SLC16A2-related disorder |
| RS1313315549 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS1313316497 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1313319587 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS1313319892 |
POGZ
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1313331250 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1313335539 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1313340299 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS1313353571 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS1313359281 |
SC5D
|
Health Risk |
Conflicting classifications of pathogenicity |
Lathosterolosis, Lathosterolosis |
| RS1313375310 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS1313391525 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1313418437 |
AMHR2
|
Health Risk |
Pathogenic |
— |
| RS1313430297 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1313433161 |
NR2F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1313473522 |
MRPS34
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation deficiency 32, Combined oxidative phosphorylation deficiency 32 |
| RS1313497913 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS1313498386 |
MYH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, proximal |
| RS1313545397 |
AK9
|
Health Risk |
Pathogenic |
Spermatogenic failure 89, Spermatogenic failure 89 |
| RS1313558579 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS1313576315 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1313578208 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homozygous familial hypercholesterolemia, Familial hypercholesterolemia |
| RS1313590454 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS1313593155 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Retinal dystrophy |
| RS1313627454 |
CASR
|
Health Risk |
Likely pathogenic |
Neonatal severe primary hyperparathyroidism, Neonatal severe primary hyperparathyroidism |
| RS1313627984 |
MSRB3
|
Health Risk |
Likely pathogenic |
— |
| RS1313634930 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1313637057 |
PRMT7
|
Health Risk |
Likely pathogenic |
Short stature-brachydactyly-obesity-global developmental delay syndrome, Short stature-brachydactyly-obesity-global developmental delay syndrome |
| RS1313637977 |
MPI
|
Health Risk |
Pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1313639936 |
NR1H4
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1313658611 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1313663918 |
RBM8A
|
Health Risk |
Pathogenic |
— |
| RS1313679502 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS1313708855 |
CC2D2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |